Possible Plastic Contamination Prompts Nationwide Ice Cream Recall
By Carole Tanzer Miller HealthDay Reporter
TUESDAY, May 20, 2025 — Nearly 18,000 tubs of ice cream and frozen yogurt have been recalled because they may contain plastic pieces.
Wells Enterprises, an Iowa-based ice cream manufacturer, voluntarily recalled the products last month. Its brands include Blue Bunny and Halo Top ice cream products, according to The Associated Press.
The nationwide recall affects 22 flavors of frozen yogurt and ice cream in three-gallon containers. They have "Best If Used By" dates from March to October 2026.
Some of the ice cream was distributed to food service suppliers and restaurants. Among them were Gordon Food Service, US Foods and Sysco Corp, and Johnny Rockets and Planet Smoothie restaurants, AP reported.
The U.S. Food and Drug Administration (FDA) lists the recall on its website but issued no press release to announce it.
If you have one of the 22 products on the FDA's recall list, do not open or consume the product. Return it to the place of purchase for a refund or throw it out so no one will eat it, the FDA recommends.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-21 06:00
Read more
- Etavopivat is the First in a New Class of Drugs to Meet Both Co-Primary Endpoints in the Phase 3 HIBISCUS Trial, Substantially Reducing Vaso-Occlusive Crisis Events and Improving Hemoglobin Response in Sickle Cell Disease
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Vitreous Floaters Confer Increased Risk for Retinal Detachment
- Elevar Therapeutics Announces FDA Acceptance for Review of New Drug Application for Lirafugratinib as Second-line Cholangiocarcinoma Treatment
- FDA Approves Lifyorli (relacorilant) Plus Nab-Paclitaxel for the Treatment of Patients with Platinum-Resistant Ovarian Cancer
- Vertex Announces US FDA Approval for Label Extensions of Alyftrek and Trikafta, Expanding Availability of These Medicines to ~95% of All People With CF in the United States
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions